Trinity Biotech | TRIB - Loan Capital


Trinity Biotech reported $16.33M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Bio-Rad Laboratories USD 802.9M 398.8M Mar/2026
EDAP TMS EUR 1.01M 13K Sep/2025
J&J USD 37.34B 183M Jun/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 25.22B 2.21B Jun/2026
Siemens EUR 41.52B 1.31B Mar/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Tosoh JPY 84.23B 9.84B Mar/2026
Trinity Biotech USD 16.33M 98.53M Dec/2025
Veracyte USD 0 0 Mar/2025